- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
A device called a bone stimulator produces an electric current with the goal of promoting bone development. It makes use of electromagnetic pulses or ultrasonic waves. Bone stimulator therapy must be administered consistently to be effective. Bone stimulators can be externally placed on the afflicted bone or surgically implanted there.
Both pulsed ultrasonic energy and low-level pulsed electromagnetic fields are produced by bone development stimulators. According to hypothesis, these energy fields encourage bone growth by aiding in tissue healing and promoting cell growth and maturity.
In order to stimulate bone formation, devices that generate either pulsed ultrasonic energy or a low-level pulsed electromagnetic field are used. These energy fields are thought to encourage bone growth by aiding in tissue healing and promoting cell creation and maturation.
The Global Ultrasound Bone Healing System market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
With the help of ultrasound technology, the EXOGEN Ultrasound Bone Healing System speeds up your body's normal fracture healing processes. repairing fractures that do not mend naturally.
Bioventus has a clinical development program me called BONES (Bioventus Observational Non-interventional EXOGEN Studies). Three direct-to-patient observational, non-interventional trials using the EXOGEN ultrasound bone healing system are part of the BONES study series.
EXOGEN uses low-intensity pulsed ultrasound (LIPUS), a safe and efficient technique, to aid in promoting the body's normal bone repair process.
will compare the incidence of fracture non unions in patients utilizing EXOGEN with patients from a national health insurance claims database who received standard of care alone. The studies will include long and small bones of upper and lower extremities and the unique design of BONES was discussed with FDA during its development.
Its primary endpoint is defined as the ability of EXOGEN to mitigate the risk of a fracture progressing to nonunion in the presence of known risk factors.
| Sl no | Topic |
| 1 | Market Segmentation |
| 2 | Scope of the report |
| 3 | Abbreviations |
| 4 | Research Methodology |
| 5 | Executive Summary |
| 6 | Introduction |
| 7 | Insights from Industry stakeholders |
| 8 | Cost breakdown of Product by sub-components and average profit margin |
| 9 | Disruptive innovation in the Industry |
| 10 | Technology trends in the Industry |
| 11 | Consumer trends in the industry |
| 12 | Recent Production Milestones |
| 13 | Component Manufacturing in US, EU and China |
| 14 | COVID-19 impact on overall market |
| 15 | COVID-19 impact on Production of components |
| 16 | COVID-19 impact on Point of sale |
| 17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
| 18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
| 19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
| 20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
| 21 | Product installation rate by OEM, 2023 |
| 22 | Incline/Decline in Average B-2-B selling price in past 5 years |
| 23 | Competition from substitute products |
| 24 | Gross margin and average profitability of suppliers |
| 25 | New product development in past 12 months |
| 26 | M&A in past 12 months |
| 27 | Growth strategy of leading players |
| 28 | Market share of vendors, 2023 |
| 29 | Company Profiles |
| 30 | Unmet needs and opportunity for new suppliers |
| 31 | Conclusion |
| 32 | Appendix |
© 2017-2025 Mobility Foresights Pvt Ltd. All rights reserved.